John Mancini Official Reviewer ACCF Board of Governors GlaxoSmithKline Merck Pfizer Sanofi-aventis None None Merck* None None (Continued) Levine et al 2011 ACCF/AHA/SCAI PCI Guideline e645 Appendix 2. Continued Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness W. Douglas Weaver Official Reviewer ACCF Board of Trustees None None None Boehringher Ingelheim (DSMB) Boston Scientific (DSMB) Duke Clinical Research Institute (Johnson & Johnson/Schering Plough)* GlaxoSmithKline NHLBI (DSMB) TIMI Study Group (Johnson & Johnson/ Bayer DSMB) None None Thomas M. Bashore Content Reviewer None None None None None None Christopher E. Buller Content Reviewer Abbott Vascular Toshiba Medical None None Novartis Regado Biosciences None None James A. Burke Content Reviewer ACCF Interventional Scientific Council None None None None None None John G. Byrne Content Reviewer ACCF Surgeons Scientific Council Edwards Lifesciences None None None None None T. Bruce Ferguson Content Reviewer ACCF Surgeons Scientific Council None None None Novadaq Technologies* None None Victor A. Ferrari Content Reviewer None None None NHLBI (DSMB) National Institute for Aging/NIH (DSMB) None None John G. Harold Content Reviewer None None None None None None Biswajit Kar Content Reviewer None None None AstraZeneca Boston Scientific Medtronic VA Cooperative Study None Morton J. Kern Content Reviewer Infraredex Merit Medical* St. Jude Medical* Volcano Therapeutics* None None None None Spencer B. King III Content Reviewer Celonova Biosciences None None Merck (DSMB) Wyeth (DSMB) None None Frederick G. Kushner Content Reviewer None None None Novartis None None David J. Maron Content Reviewer None None Cardiovascular Care Affiliates* None None Plaintiff, acute coronary syndrome, Douglass A. Morrison Content Reviewer None None None None None None (Continued) Appendix 2. 